Vaccination

3 doses of Pfizer–BioNTech COVID vaccine better than 2

A Kaiser Permanente study published Feb. 14, 2022, in The Lancet Regional Health-Americas found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine conferred higher effectiveness against infection and ...

Vaccination

Mortality study reinforces safety of COVID-19 vaccinations

COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren't vaccinated, according to Kaiser Permanente research published October 22 in the Centers for Disease Control and Prevention's Morbidity ...

page 3 from 7